PAMIR OZAN (Chief Financial Officer) purchased 6.69K shares of NIAGEN BIOSCIENCE, INC. on the open market
Open‑market purchase worth $45.6K. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 11/17/2025ACC: 0001834681-25-000005
Officer· Chief Financial Officer
Since Feb 2026
+6.69K
Net shares
Net buyer
$45.6K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
6.69K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+4.46K
Price / share
$6.81
Trade value
$30.41K
% of position
153.6%
11/14/2025
2.91K→7.37K
Common Stock
Indirect
Shares
+2.22K
Price / share
$6.85
Trade value
$15.21K
% of position
New position
11/14/2025
0.00→2.22K
Total
Net shares
+6.69K
Net value
$45.62K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/14/2025 | P · Purchase | +4.46K | $6.81 | $30.41K | 153.6% | 2.91K | 7.37K |
| Common Stock Indirect | 11/14/2025 | P · Purchase | +2.22K | $6.85 | $15.21K | New position | 0.00 | 2.22K |
| Total | +6.69K | $45.62K | ||||||
Derivative Transactions0
No derivative transactions reported